Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial
Authors:
Open Access
- 28 July 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1139872
Abstract
Background: Remimazolam besylate is a novel ultra-short-acting benzodiazepine that can potentially be a safe and effective sedative in intensive care units. This study aims to assess whether remimazolam besylate is not inferior to propofol in maintaining mild-to-moderate sedation in critically ill patients receiving long-term mechanical ventilation.Methods and analysis: This is a multicenter, randomized, single-blind, propofol-controlled, non-inferiority study. Eligible patients are randomly assigned to receive remimazolam besylate or propofol in a 1:1 ratio to maintain a Richmond Agitation–Sedation Scale score between −3 and 0. When patients are under-sedated, rescue sedation of dexmedetomidine is added. The primary outcome is the percentage of time in the target sedation range. The secondary outcomes are hours free from the invasive ventilator in 7 days, successful extubation in 7 days, and weaning time, the length of intensive care unit stay, the length of hospital stay, and mortality in 28 days. Modified intention-to-treat and safety analysis is performed.Clinical trial registration number:https://clinicaltrials.gov/ct2/show/NCT05555667.Keywords
This publication has 21 references indexed in Scilit:
- Group sequential designs for negative binomial outcomesStatistical Methods in Medical Research, 2018
- Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989–20141Emerging Infectious Diseases, 2016
- A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)Anesthesia & Analgesia, 2012
- Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter studyCritical Care, 2009
- Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]Critical Care, 2005
- A low-dose remifentanil infusion is well tolerated for sedation in mechanically ventilated, critically-ill patientsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2002
- The Richmond Agitation–Sedation Scale: Validity and Reliability in Adult Intensive Care Unit PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Delirium in Mechanically Ventilated PatientsJAMA, 2001
- Sedation in the Intensive Care UnitJAMA, 2000
- Postoperative Infections Traced to Contamination of an Intravenous Anesthetic, PropofolNew England Journal of Medicine, 1995